2. Signaling Pathways
  3. Cell Cycle/DNA Damage
  4. Wee1

Wee1 (Wee1蛋白激酶)

Wee1 is a nuclear kinase belonging to the Ser/Thr family of protein kinases in the fission yeast Schizosaccharomyces pombe (S. pombe). Wee1 has amolecular mass of 96 kDa and it is a key regulator of cell cycle progression. Wee1 influences cell size by inhibiting the entry into mitosis, through inhibiting Cdk1. Wee1 has homologues in many other organisms, including mammals. Wee1 inhibits Cdk1 by phosphorylating it on two different sites, Tyr15 and Thr14. Cdk1 is crucial for the cyclin-dependent passage of the various cell cycle checkpoints. At least three checkpoints exist for which the inhibition of Cdk1 by Wee1 is important: G2/M checkpoint, Cell size checkpoint, DNA damage checkpoint. Wee1 is shown to phosphorylate histone H2B at tyrosine 37 residue which regulates global expression of histones.
WEE1 subfamily includes PMYT1.

Wee1 亚型特异性产品:

Wee1 Isoform Comparison
Cat. No. Product Name Effect Purity Chemical Structure
  • HY-148065
    FMF-06-098-1 Inhibitor 98.77%
    FMF-06-098-1 是一种多靶点激酶 PROTAC 降解剂。FMF-06-098-1 可以降解 AAK1, AΒL2, AURKA, AURKB, BUBIB, CDC7, CDK1, CDK12, CDK13, CDK2, CDK4, CDk6, CDK7, CDK9, CHEK1, CSNKID, EPHA1, PER, FGFR1, GAK, IRAK4, ITK, LIMK2, MAP4K2, MAP4K3, MAPK6, MAPK7, MARK4, MELK, PKN3, PLK4, PRKAA1, PTK2, PTK6, RPS6KA4, S1K2, STK35, TNK2, UHMK1, ULK1，WEE1 (粉色：靶蛋白配体 (HY-169396)；蓝色：VHL 配体 (HY-112078)；黑色：连接体 (HY-124380))。
    FMF-06-098-1
  • HY-145817B
    (R)-lunresertib Inhibitor 99.87%
    (R)-lunresertib 是一个 膜相关酪氨酸和苏氨酸特异性 cdc2 抑制激酶 (Myt1) (Gene name PKMYT1) 抑制剂，IC50 为 1360 nM。(R)-lunresertib 可用于 Myt1 介导的癌症研究。
    (R)-lunresertib
  • HY-170517
    PKMYT1-IN-8 Inhibitor 99.31%
    PKMYT1-IN-8 (Compound 137) 是 PKMYT1 的抑制剂，IC50 为 9 nM。PKMYT1-IN-8 也可以抑制 EPHB3，EPHA1，KIT，EPHB1，EPHA2，EPHA3 和 EPHB2，IC50 分别为 1.79，3.17，4.29，6.32，6.83，8.10 和 10.9 μM。PKMYT1-IN-8 可以抑制癌细胞 OVCAR3 的增殖，GI50 为 2.02 μM。
    PKMYT1-IN-8
  • HY-145666
    Myt1-IN-3 Inhibitor 99.14%
    Myt1-IN-3 是一种有效的 膜相关酪氨酸和苏氨酸特异性 cdc2 抑制激酶 (Myt1) (Gene name PKMYT1) 抑制剂，IC50 小于 10 nM (WO2021195782 A1, compound 95)。
    Myt1-IN-3
  • HY-168654
    WEE1 degrader 1 Degrader
    WEE1 degrader 1 (Compound 10) 是 Wee1 降解剂，对 Wee1 的 DC50 值为 1.5 nM。WEE1 degrader 1 具有抗癌细胞增殖作用。
    WEE1 degrader 1
  • HY-163490
    PKMYT1-IN-1 Inhibitor
    PKMYT1-IN-1 (Compound 1) 是膜相关酪氨酸和苏氨酸激酶 (PKMYT1) 的抑制剂，IC50 为 8.8 nM。PKMYT1-IN-1 抑制肿瘤细胞 HCC1569 的增殖，IC50 为 42 nM。
    PKMYT1-IN-1
  • HY-161880
    WEE1-IN-10 Inhibitor 99.32%
    WEE1-IN-10 (compound 77) 是一种 Wee1 激酶抑制剂。WEE1-IN-10 对 LOVO 细胞生长有抑制活性，IC50 为 0.524 μM。WEE1-IN-10 可用于研究由 Wee1 活性异常引起的疾病。
    WEE1-IN-10
  • HY-169946
    WEE1/PKMYT1-IN-1 Inhibitor
    WEE1/PKMYT1-IN-1 (compound 75) 是一种有效且具有口服活性的 WEE1 和 PKMYT1 抑制剂。WEE1/PKMYT1-IN-1 表现出抗增殖活性。
    WEE1/PKMYT1-IN-1
  • HY-163697
    WEE1-IN-7 Inhibitor
    WEE1-IN-7 (compound 12h) 是一种有效的具有口服活性的 WEE1 抑制剂，其IC50值为 2.1 nM。WEE1-IN-7 诱导细胞凋亡 (apoptosis) 和细胞周期停滞于 S 期。WEE1-IN-7 具有抗肿瘤活性。
    WEE1-IN-7
  • HY-10993R
    Adavosertib (Standard) Inhibitor
    Adavosertib (Standard)是 Adavosertib 的分析标准品。本产品用于研究及分析应用。Adavosertib (AZD-1775; MK-1775) 是一种有效的 Wee1 抑制剂，IC50 值为 5.2 nM。
    Adavosertib (Standard)
  • HY-145665
    Myt1-IN-2 Inhibitor
    Myt1-IN-2 是一种有效的 膜相关酪氨酸和苏氨酸特异性 cdc2 抑制激酶 (Myt1) (Gene name PKMYT1) 抑制剂，IC50 <10 nM。Myt1-IN-2 具 有抗癌作用。
    Myt1-IN-2
  • HY-163491
    PKMYT1-IN-2 Inhibitor
    PKMYT1-IN-2 (compound 2) 是一种有效的 PKMYT1 抑制剂，IC50 为 5.7 nM。PKMYT1-IN-2 抑制 HCC1569 细胞的生长，IC50 为 22 nM。
    PKMYT1-IN-2
  • HY-168180
    WEE1-IN-11 Inhibitor
    WEE1-IN-11 (Compound 13) 是一种有效的 CDK2 抑制剂，其 IC50为 2.0 nM。WEE1-IN-11 对 NCI-H446、A427、OVCAR3、C33A 和 WiDr 细胞有抑制作用，IC50 分别为 93.9、34.5、86.7、23.1 和 85 nM。
    WEE1-IN-11
  • HY-161871
    WEE1-IN-8 Inhibitor
    WEE1-IN-8 (Compound 55) 是选择性的 WEE1 抑制剂，其 IC50 值为 0.98 nM。WEE1-IN-8 (Compound 55) 可用于胰腺癌、卵巢癌、结肠癌、子宫浆液癌等多种癌症研究。
    WEE1-IN-8
  • HY-161879
    WEE1-IN-9 Inhibitor
    WEE1-IN-9 (Compound 1) 是一种 Wee1 抑制剂，可以用于癌症的研究。
    WEE1-IN-9
  • HY-157443
    Myt1-IN-4 Inhibitor
    Myt1-IN-4 (21) 是具有口服活性的、选择性的 膜相关酪氨酸和苏氨酸特异性 cdc2 抑制激酶 (Myt1) (Gene name PKMYT1) 抑制剂，其IC50 值为2.6 nM。Myt1-IN-4 (21) 具有抗肿瘤活性。
    Myt1-IN-4
  • HY-160530
    WEE1-IN-6 Inhibitor
    WEE1-IN-6 (compound 110) 是一种口服活性 WEE1 抑制剂，DC50 值≤ 100 nM。WEE1-IN-6 抑制细胞增殖。
    WEE1-IN-6
  • HY-162849
    PKMYT1-IN-3 Inhibitor
    PKMYT1-IN-3 (compound 8ma) 是一种有效和选择性的 PKMYT1 抑制剂，IC50 值为 16.5 nM。PKMYT1-IN-3 具有抗肿瘤活性。
    PKMYT1-IN-3
  • HY-172807
    p38α-IN-9 Inhibitor
    p38α-IN-9 (Compound 2015) 是一种 p38α 抑制剂，可阻断 p38α 的酶活性，其 IC50 低于 20 nM。p38α-IN-9 可抑制 MK2T334 磷酸化。p38α-IN-9 可激活 Cdc25b 和 Cdc25c，同时使 Wee1 失活，导致有丝分裂灾难、非整倍体或多倍体以及 DNA 损伤。p38α-IN-9 可抑制结直肠癌 (CRC) 转移。
    p38α-IN-9
  • HY-143342
    LEB-03-144
    LEB-03-144 是一个 WEE1 DUBTAC (去泛素化酶靶向嵌合体)，通过 C3 烷基连接剂将 AZD1775 (Adavosertib) 与 OTUB1 招募者 EN523 连接起来。LEB-03-144 在 HEP3B 肝癌细胞中可显著稳定 WEE1。
    LEB-03-144
Wee1 Isoform Comparison

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z